News

Pyrodex Founder Joins USP Expert Panel on the Monocyte Activation Test

Vic KingOctober 8, 2026

PyroDex on the World Stage: Saudi Arabia, Riyadh, and Seoul

Vic KingOctober 7, 2026

Out of the Endotoxin Box: Addressing Pyrogen Diversity Challenges Using the Monocyte Activation Test (MAT)

Vic KingMarch 8, 2026

The Hidden Cost of Unsafe Drugs (Podcast)

Vic KingApril 29, 2025

EndoSummit 2025: Advancing Endotoxin Testing for Safer Medicine

Vic KingMarch 11, 2025

PyroDex Contributes to Landmark NIST Study on Sterility Testing

Vic KingMarch 11, 2025

Join me at the PDA Capital Area Quarterly Meeting

Vic KingSeptember 22, 2024

Join me at PharmaLab Congress 2024!

Vic KingAugust 19, 2024

Pyrodex Founder Honored for Leadership in Biotechnology

Vic KingJune 10, 2024

Out of the Endotoxin Box: Rethinking Pyrogens

Vic KingNovember 6, 2023

Endotoxins Are Not All The Same. We Shouldn't Test As If They Are.

Vic KingNovember 6, 2023

Profile of Pyrodex Founder Djik Maouyo

Vic KingApril 3, 2023

Get one FREE sample with your first order!

Vic KingJanuary 5, 2023

Redemption of Medical Drugs in Clinical Trials

Vic KingMay 14, 2021

Pyrodex Testing's Capability Statement

Vic KingMay 5, 2020

Monocyte Activation Testing for Successful Clinical Trials

Vic KingMarch 5, 2020

PyroDex Is Now Certified Proficient for MAT Testing by European Standards

Vic KingJuly 3, 2019

The Monocyte Activation Test (MAT): A relevant alternative to the compendial sterility test

Djik MaouyoMarch 14, 2019

Is the Monocyte Activation Test a Viable Alternative to Traditional Tests?

An article by Pyrodex Testing founder and principal Djik Maouyo was published in January by the PDA Letter, the magazine of the Parenteral Drug Association.

Vic KingFebruary 4, 2019

Pyrodex Video by the Lifebridge BioIncubator

Pyrodex is a proud member of the Lifebridge Health BioIncubator at Sinai Hospital - Maryland's only hospital-based bioincubator.

Vic KingJanuary 7, 2019

Copyright PyroDex LLC · Privacy Settings · Site by King Haus